Login
$RYTM
$89.47 +$0.20 (0.22%) Close

$RYTM SEC Filings

Filed On Filing
13 Oct 2026 SCHEDULE 13G
14 Sep 2026 144
14 Sep 2026 Form 4: Meeker David P, Director

Received 50,000 shares by exercise or conversion ($303K) · Sold 50,000 shares ($5.13M)

01 Sep 2026 Form 4: Smith Hunter C, Chief Financial Officer

Received 57,187 shares by exercise or conversion ($1.47M) · Sold 62,774 shares ($6.62M)

31 Aug 2026 144
18 Aug 2026 Form 4: Joshi Manher, Chief Medical Officer

Granted 50,000 Stock Options (Right to Buy) · Granted 25,000 Restricted Stock Units

18 Aug 2026 Form 3: Joshi Manher, Chief Medical Officer

No securities owned

17 Aug 2026 Form 4: Shulman Joseph, Chief Technical Officer

Received 2,024 shares by exercise or conversion ($13.8K) · Sold 5,079 shares ($608K)

17 Aug 2026 Form 4: Garfield Alastair, Chief Scientific Officer

Sold 7,763 shares ($913K)

14 Aug 2026 Form 4: Lee Jennifer Kayden, EVP, Head of North America

Received 56,601 shares by exercise or conversion ($997K) · Sold 75,834 shares ($8.9M)

14 Aug 2026 Form 4: Mazabraud Yann, EVP, Head of International

Received 46,625 shares by exercise or conversion ($317K) · Sold 57,000 shares ($6.62M)

13 Aug 2026 144
13 Aug 2026 144
13 Aug 2026 144
12 Aug 2026 144
11 Aug 2026 144
10 Aug 2026 144
04 Aug 2026 10-Q
04 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
02 Jul 2026 Form 4: Garfield Alastair, Chief Scientific Officer

Received 4,445 shares by exercise or conversion · Gave up 2,150 shares to cover exercise price or tax ($237K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support